Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma

PURPOSE: Late cardiac complications from thoracic radiation of patients with Hodgkin lymphoma are of great concern. The authors investigated whether cardiac biomarkers could identify patients with early cardiac damage from thoracic radiation. MATERIALS AND METHODS: Following completion of anthracycl...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Part Ther
Prif Awduron: Guzhva, Lidia, Mendenhall, Nancy P., Morris, Christopher G., Flampouri, Stella, Hoppe, Bradford S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Particle Therapy Co-operative Group 2017
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6871553/
https://ncbi.nlm.nih.gov/pubmed/31773007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14338/IJPT-D-17-00022
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg